Drug-coated balloons for infrapopliteal disease: Digging deep to understand the impact of a negative trial

Journal of the American College of Cardiology

Volumn 64, Issue 15, 2014, Pages 1577-1579

  Laird, John R ^a   Armstrong, Ehrin J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

amputation; angioplasty; balloon; critical limb ischemia; diabetes mellitus; limb salvage; paclitaxel; peripheral vascular disease

Indexed keywords

BUTYRYL TRIHEXYL CITRATE; CONTRAST MEDIUM; EXCIPIENT; IOPROMIDE; PACLITAXEL; SHELLAC; UNCLASSIFIED DRUG; UREA;

ATHEROSCLEROSIS; BALLOON; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; DRUG COATED BALLOON; DRUG DELIVERY SYSTEM; EDITORIAL; FEMOROPOPLITEAL LESION; HUMAN; IN-STENT RESTENOSIS; INFRAPOPLITEAL OCCLUSIVE DISEASE; LIPOPHILICITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; VASCULAR DISEASE; VASCULAR LESION; ARTERIAL OCCLUSIVE DISEASES; DRUG ELUTING STENT; FEMALE; ISCHEMIA; LEG; MALE; POPLITEAL ARTERY; PROCEDURES; VASCULAR SURGERY; VASCULARIZATION;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; DRUG-ELUTING STENTS; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; POPLITEAL ARTERY; VASCULAR SURGICAL PROCEDURES;

EID: 84908131917     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.960     Document Type: Editorial

References (19)

1. B. Scheller, U. Speck, and A. Schmitt Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation J Am Coll Cardiol 42 2003 1415 1420
2. B. Scheller, U. Speck, and C. Abramjuk Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 2004 810 814
3. C.J. Creel, M.A. Lovich, and E.R. Edelman Arterial paclitaxel distribution and deposition Circ Res 86 2000 879 884
4. U. Speck, B. Cremers, and B. Kelsch Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Circ Cardiovasc Interv 5 2012 392 400
5. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
6. R.A. Byrne, F.J. Neumann, and J. Mehilli Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
7. A. Latib, A. Colombo, and F. Castriota A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study J Am Coll Cardiol 60 2012 2473 2480
8. A. Micari, A. Cioppa, and G. Vadala Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry J Am Coll Cardiol Intv 5 2012 331 338
9. G. Tepe, T. Zeller, and T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
10. M. Werk, S. Langner, and B. Reinkensmeier Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
11. D. Scheinert, S. Duda, and T. Zeller The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty J Am Coll Cardiol Intv 7 2014 10 19
12. E. Stabile, V. Virga, and L. Salemme Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis J Am Coll Cardiol 60 2012 1739 1742
13. A. Schmidt, M. Ulrich, and B. Winkler Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal disease Catheter Cardiovasc Interv 76 2010 1047 1054
14. A. Schmidt, M. Piorkowski, and M. Werner First experience with drug-eluting balloons in infrapopliteal arteries restenosis rate and clinical outcome J Am Coll Cardiol 58 2011 1105 1109
15. F. Liistro, I. Porto, and P. Angioli Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia Circulation 128 2013 615 621
16. T. Zeller, I. Baumgartner, D. Scheinert for the IN.PACT DEEP Trial Investigators Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial J Am Coll Cardiol 64 2014 1568 1576
17. M. Romiti, M. Albers, and F.C. Brochado-Neto Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia J Vasc Surg 47 2008 975 981
18. J.R. Laird, T. Zeller, and B.H. Gray Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial J Endovasc Ther 13 2006 1 11
19. K.J. Rocha-Singh, M. Jaff, and J. Joye Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: The XCELL trial Catheter Cardiovasc Interv 15 2012 1042 1051